Why Medication Prices May Climb as Oil Markets Grow More Volatile

Oil prices have surged dramatically in recent months, reaching some of their highest levels in years. While many associate rising crude oil costs primarily with fuel and transportation expenses, the effects extend far beyond the energy sector. Medication production is one of the industry's most directly affected because many pharmaceutical raw materials and manufacturing processes depend heavily on oil derived chemicals. As crude prices rise, the cost of producing, transporting, and distributing medications increases accordingly [1].

Oil’s Critical Role in Medication Production

A significant portion of pharmaceutical chemistry is rooted in oil derived inputs. Industry analyses indicate that approximately 90-99% of raw materials used in pharmaceutical manufacturing are connected to oil-based chemicals [1]. This means that many widely used medications including paracetamol, ibuprofen, and metformin depend on oil derived ingredients and are therefore sensitive to rising crude oil prices [1].  

Pharmaceutical operations also require a wide array of oil linked intermediates, solvents, and excipients used in formulation, tableting, compounding, and packaging. As energy markets tighten, these inputs become more expensive, contributing to rising medication production costs [2].


Rising Costs Throughout the Supply Chain

The impact of higher oil prices is felt across the entire medication supply chain. Healthcare supply chain research shows that raw material, freight, and shipping expenses continue to rise, adding pressure to pharmaceutical distributors and healthcare providers [2].

Additional industry reporting highlights growing logistical challenges:

  • Air freight rates have increased by fifteen to thirty percent

  • Shipping delays have lengthened by ten to twenty days

  • Container costs have surged up to three times higher

These supply chain pressures elevate operating expenses from manufacturing through final distribution [1].

Oil Prices Have Risen Dramatically

Reliable energy market data shows just how significant this price surge has been. Brent crude has climbed to $109.75 per barrel, representing a 53.51% increase over the prior month and a 52.09% increase compared with one year earlier [3].

Official government energy forecasts further confirm sharp upward movement in oil pricing throughout 2026, noting that rising crude prices have contributed to substantial volatility in global energy markets [4].

These rapid increases significantly heighten operating costs for industries that depend on oil linked to raw materials, including pharmaceutical manufacturing.

What This Means for Medication Prices

Multiple factors point to continued upward pressure on medication costs:

1. Increased costs for essential drug ingredients

With ninety-to-ninety nine percent of pharmaceutical raw materials tied to oil derived inputs, rising crude prices directly elevate production costs [1].

2. Higher transportation and logistics expenses

Air freight surcharges, extended shipping timelines, and elevated container prices all raise the cost of distributing medications and chemical inputs [1].

3. Rising costs for solvents, excipients, and packaging materials

Many components used throughout pharmaceutical processing rise in cost alongside oil prices, amplifying overall manufacturing expenses [2].

Conclusion

Oil prices influence far more than transportation. They shape the cost structure of pharmaceutical production at every level. With crude oil rising more than fifty percent on both month over month and year over year timelines, the entire medication supply chain is experiencing significant cost pressure. From oil derived raw materials to global logistics, rising oil prices continue to push medication costs upward.

Understanding this connection between energy markets and pharmaceutical production is essential for anticipating future pricing trends and ensuring continued patient access to needed medications.


By Sarah Cirildo, PharmD

For questions, e-mail pharmd@prodigyrx.com


Citations

  1. Free Press Journal. Oil crisis may push drug prices higher: supply chain pressure hits paracetamol and APIs. Published 2026. Accessed March 2026. https://www.freepressjournal.in/business/oil-crisis-may-push-drug-prices-higher-supply-chain-pressure-hits-paracetamol-apis

  2. Vizient. Summer 2025 Spend Management Outlook: continued cost pressures across the healthcare supply chain in 2026. Published July 29, 2025. Accessed March 2026. https://www.vizientinc.com/newsroom/news-releases/2025/vizient-projects-continued-cost-pressures-across-the-healthcare-supply-chain-in-2026

  3. Trading Economics. Brent crude oil price data. Updated March 2026. Accessed March 2026. https://tradingeconomics.com/commodity/brent-crude-oil

  4. U.S. Energy Information Administration (EIA). Short‑Term Energy Outlook. Published March 2026. Accessed March 2026. https://www.eia.gov/outlooks/steo/

Next
Next

Rotator Cuff Tears in Workers’ Compensation: Medications, Recovery, and Return to Work